Buy salesforce.com (CRM) Amid Cautious Sentiment - Stifel
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Stifel analyst om Tom Roderick reiterated his Buy rating and $93 price target on salesforce.com (NYSE: CRM) ahead of results on August 31st, after the market close. The analyst said there is no better time to buy CRM then when the sentiment light starts flashing yellow.
Roderick said while recent Street sentiment shifting toward a more cautious stance, they see a setup in the stock eerily similar to the months after salesforce.com acquired ExactTarget in 2013.
He said the temptation to try and time a near-term cautious trading call might seem appealing to some, but they think it's a myopic view.
"CRM has simply become a second half stock, and we see no compelling reason for investors to get spooked out of the stock in front of the Dreamforce in October," he said.
Shares of salesforce.com closed at $78.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Checkpoint Software (CHKP) PT Raised to $94 at Stifel Following 4Q Beat
- Barclays Upgrades Southwestern Energy (SWN) to Equalweight
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS View
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!